This company listing is no longer active
AdderaCare Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Wichtige Informationen
-43.9%
Wachstumsrate der Gewinne
-39.3%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 6.2% |
| Wachstumsrate der Einnahmen | 13.2% |
| Eigenkapitalrendite | -20.3% |
| Netto-Marge | -9.5% |
| Letzte Ertragsaktualisierung | 30 Sep 2022 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Is Now An Opportune Moment To Examine AdderaCare AB (STO:ADDERA)?
Aug 31
We Think AdderaCare (STO:ADDERA) Can Stay On Top Of Its Debt
Jun 18Investors Could Be Concerned With AdderaCare's (STO:ADDERA) Returns On Capital
Apr 06AdderaCare (STO:ADDERA) Has A Pretty Healthy Balance Sheet
Jan 27AdderaCare (STO:ADDERA) Will Want To Turn Around Its Return Trends
Nov 20These 4 Measures Indicate That AdderaCare (STO:ADDERA) Is Using Debt Reasonably Well
Aug 29AdderaCare (STO:ADDERA) Could Be Struggling To Allocate Capital
Aug 02What Does AdderaCare AB's (STO:ADDERA) Share Price Indicate?
May 24Here's What's Concerning About AdderaCare's (STO:ADDERA) Returns On Capital
Apr 28We Think That There Are Some Issues For AdderaCare (STO:ADDERA) Beyond Its Promising Earnings
Mar 03Is There Now An Opportunity In AdderaCare AB (STO:ADDERA)?
Feb 20
We Think AdderaCare (STO:ADDERA) Has A Fair Chunk Of Debt
Jan 16Is It Time To Consider Buying AdderaCare AB (STO:ADDERA)?
Nov 22Aufschlüsselung der Einnahmen und Ausgaben
Wie AdderaCare Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 22 | 279 | -27 | 73 | 0 |
| 30 Jun 22 | 283 | -25 | 74 | 0 |
| 31 Mar 22 | 271 | 5 | 72 | 0 |
| 31 Dec 21 | 248 | 1 | 67 | 0 |
| 30 Sep 21 | 231 | 0 | 63 | 0 |
| 30 Jun 21 | 221 | 2 | 59 | 0 |
| 31 Mar 21 | 203 | 10 | 53 | 0 |
| 31 Dec 20 | 205 | 10 | 55 | 0 |
| 30 Sep 20 | 198 | 5 | 59 | 0 |
| 30 Jun 20 | 199 | 5 | 60 | 0 |
| 31 Mar 20 | 208 | -4 | 63 | 0 |
| 31 Dec 19 | 206 | -2 | 61 | 0 |
| 30 Sep 19 | 206 | 3 | 59 | 0 |
| 30 Jun 19 | 201 | 1 | 58 | 0 |
| 31 Mar 19 | 203 | 3 | 57 | 0 |
| 31 Dec 18 | 192 | 1 | 56 | 0 |
| 30 Sep 18 | 177 | 1 | 50 | 0 |
| 30 Jun 18 | 161 | 1 | 45 | 0 |
| 31 Mar 18 | 136 | -1 | 40 | 0 |
| 31 Dec 17 | 128 | 4 | 33 | 0 |
| 30 Sep 17 | 116 | 5 | 29 | 0 |
| 30 Jun 17 | 105 | 4 | 26 | 0 |
| 31 Mar 17 | 102 | 7 | 23 | 0 |
| 31 Dec 16 | 94 | 6 | 21 | 0 |
Qualität der Erträge: ADDERA is currently unprofitable.
Wachsende Gewinnspanne: ADDERA is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: ADDERA is unprofitable, and losses have increased over the past 5 years at a rate of 43.9% per year.
Beschleunigtes Wachstum: Unable to compare ADDERA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: ADDERA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-17.8%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: ADDERA has a negative Return on Equity (-20.34%), as it is currently unprofitable.